Safety of ultrasound-guided percutaneous injection of alcohol as a scolicidal agent for the treatment of liver hydatid cysts

Background: Hydatid disease is a health problem in the developing world. Percutaneous therapy with various scolicidal agents has been described; however, there is a paucity of literature on the use of absolute alcohol injection without reaspiration as a sole scolicidal agent. The study carried out i...

Full description

Bibliographic Details
Main Authors: V John Samuel, Arul Babu, Vinu Moses, M J Aparna, Munawwar Ahmed, George M Varghese, Philip Joseph, Shyamkumar N Keshava
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Current Medical Issues
Subjects:
Online Access:http://www.cmijournal.org/article.asp?issn=0973-4651;year=2023;volume=21;issue=1;spage=19;epage=25;aulast=Samuel
_version_ 1797904944138813440
author V John Samuel
Arul Babu
Vinu Moses
M J Aparna
Munawwar Ahmed
George M Varghese
Philip Joseph
Shyamkumar N Keshava
author_facet V John Samuel
Arul Babu
Vinu Moses
M J Aparna
Munawwar Ahmed
George M Varghese
Philip Joseph
Shyamkumar N Keshava
author_sort V John Samuel
collection DOAJ
description Background: Hydatid disease is a health problem in the developing world. Percutaneous therapy with various scolicidal agents has been described; however, there is a paucity of literature on the use of absolute alcohol injection without reaspiration as a sole scolicidal agent. The study carried out in a tertiary hospital aimed to prospectively evaluate the safety and outcomes of ultrasound-guided percutaneous injection of alcohol for liver hydatid cyst. Methodology: Consecutive patients with liver hydatid cysts were evaluated with ultrasound, classified according to the WHO classification between June 2012 and January 2020. Eligible patients underwent ultrasound-guided percutaneous therapy after three courses of oral albendazole. Patients having elevated cyst fluid bilirubin levels were excluded. Patients who underwent percutaneous alcohol injection were followed up clinically and with imaging. Data were entered in Microsoft Excel spreadsheet and analyzed. Results: Fifty-two consecutive patients with hydatid cyst were evaluated during the study. Among these, 27 patients underwent percutaneous alcohol injection. Follow-up data were available for 25 patients. There was a favorable imaging outcome in 21/25 (84%). One patient developed anaphylaxis during cyst access, which was managed medically with an uneventful recovery. No instances of cholangitis or sepsis following injection were observed. Conclusion: Percutaneous alcohol injection therapy for liver hydatid cysts is a minimally invasive, safe, and an effective procedure in selected group of patients.
first_indexed 2024-04-10T09:57:04Z
format Article
id doaj.art-de1bace4fbb9400fba7f994526827923
institution Directory Open Access Journal
issn 0973-4651
2666-4054
language English
last_indexed 2024-04-10T09:57:04Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Current Medical Issues
spelling doaj.art-de1bace4fbb9400fba7f9945268279232023-02-16T12:13:30ZengWolters Kluwer Medknow PublicationsCurrent Medical Issues0973-46512666-40542023-01-01211192510.4103/cmi.cmi_71_22Safety of ultrasound-guided percutaneous injection of alcohol as a scolicidal agent for the treatment of liver hydatid cystsV John SamuelArul BabuVinu MosesM J AparnaMunawwar AhmedGeorge M VarghesePhilip JosephShyamkumar N KeshavaBackground: Hydatid disease is a health problem in the developing world. Percutaneous therapy with various scolicidal agents has been described; however, there is a paucity of literature on the use of absolute alcohol injection without reaspiration as a sole scolicidal agent. The study carried out in a tertiary hospital aimed to prospectively evaluate the safety and outcomes of ultrasound-guided percutaneous injection of alcohol for liver hydatid cyst. Methodology: Consecutive patients with liver hydatid cysts were evaluated with ultrasound, classified according to the WHO classification between June 2012 and January 2020. Eligible patients underwent ultrasound-guided percutaneous therapy after three courses of oral albendazole. Patients having elevated cyst fluid bilirubin levels were excluded. Patients who underwent percutaneous alcohol injection were followed up clinically and with imaging. Data were entered in Microsoft Excel spreadsheet and analyzed. Results: Fifty-two consecutive patients with hydatid cyst were evaluated during the study. Among these, 27 patients underwent percutaneous alcohol injection. Follow-up data were available for 25 patients. There was a favorable imaging outcome in 21/25 (84%). One patient developed anaphylaxis during cyst access, which was managed medically with an uneventful recovery. No instances of cholangitis or sepsis following injection were observed. Conclusion: Percutaneous alcohol injection therapy for liver hydatid cysts is a minimally invasive, safe, and an effective procedure in selected group of patients.http://www.cmijournal.org/article.asp?issn=0973-4651;year=2023;volume=21;issue=1;spage=19;epage=25;aulast=Samuelalcohol sclerotherapyhepatic hydatid cystpercutaneous injection
spellingShingle V John Samuel
Arul Babu
Vinu Moses
M J Aparna
Munawwar Ahmed
George M Varghese
Philip Joseph
Shyamkumar N Keshava
Safety of ultrasound-guided percutaneous injection of alcohol as a scolicidal agent for the treatment of liver hydatid cysts
Current Medical Issues
alcohol sclerotherapy
hepatic hydatid cyst
percutaneous injection
title Safety of ultrasound-guided percutaneous injection of alcohol as a scolicidal agent for the treatment of liver hydatid cysts
title_full Safety of ultrasound-guided percutaneous injection of alcohol as a scolicidal agent for the treatment of liver hydatid cysts
title_fullStr Safety of ultrasound-guided percutaneous injection of alcohol as a scolicidal agent for the treatment of liver hydatid cysts
title_full_unstemmed Safety of ultrasound-guided percutaneous injection of alcohol as a scolicidal agent for the treatment of liver hydatid cysts
title_short Safety of ultrasound-guided percutaneous injection of alcohol as a scolicidal agent for the treatment of liver hydatid cysts
title_sort safety of ultrasound guided percutaneous injection of alcohol as a scolicidal agent for the treatment of liver hydatid cysts
topic alcohol sclerotherapy
hepatic hydatid cyst
percutaneous injection
url http://www.cmijournal.org/article.asp?issn=0973-4651;year=2023;volume=21;issue=1;spage=19;epage=25;aulast=Samuel
work_keys_str_mv AT vjohnsamuel safetyofultrasoundguidedpercutaneousinjectionofalcoholasascolicidalagentforthetreatmentofliverhydatidcysts
AT arulbabu safetyofultrasoundguidedpercutaneousinjectionofalcoholasascolicidalagentforthetreatmentofliverhydatidcysts
AT vinumoses safetyofultrasoundguidedpercutaneousinjectionofalcoholasascolicidalagentforthetreatmentofliverhydatidcysts
AT mjaparna safetyofultrasoundguidedpercutaneousinjectionofalcoholasascolicidalagentforthetreatmentofliverhydatidcysts
AT munawwarahmed safetyofultrasoundguidedpercutaneousinjectionofalcoholasascolicidalagentforthetreatmentofliverhydatidcysts
AT georgemvarghese safetyofultrasoundguidedpercutaneousinjectionofalcoholasascolicidalagentforthetreatmentofliverhydatidcysts
AT philipjoseph safetyofultrasoundguidedpercutaneousinjectionofalcoholasascolicidalagentforthetreatmentofliverhydatidcysts
AT shyamkumarnkeshava safetyofultrasoundguidedpercutaneousinjectionofalcoholasascolicidalagentforthetreatmentofliverhydatidcysts